Enasidenib Plus Azacitidine Significantly Improves Complete Remission And Overall Response Compared With Azacitidine Alone In Patients With Newly Diagnosed Acute Myeloid Leukemia (Aml) With Isocitrate Dehydrogenase 2 (Idh2) Mutations: Interim Phase Ii Results From An Ongoing, Randomized Study